Go Nagao

Tokyo Medical University

Papers

2

Total Citations

42

H-Index

2

About

Go Nagao is a leading figure in urologic oncology, with a research focus on the clinical outcomes and health service implications of robotic surgery for prostate cancer. His major contributions center on understanding how robot-assisted radical prostatectomy (RARP) affects patient prognosis and treatment-seeking behavior, particularly within the Japanese healthcare system. In his landmark 2014 study, Nagao analyzed a cohort of 784 Japanese patients to develop a risk stratification model for predicting biochemical recurrence after RARP, providing critical insights for postoperative management. This work, which has accumulated 31 citations, remains a key reference in the field. Expanding his impact, Nagao’s 2017 investigation into the geographical accessibility of surgical robot technology revealed how the introduction of robotic surgery in Japan in 2012 significantly altered patient behavior, with men traveling farther to undergo the procedure. This 11-citation study highlights the intersection of surgical innovation and healthcare equity. Nagao’s research is notable for its dual focus on clinical precision and real-world access, making him a vital voice in the evolution of minimally invasive prostate cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
42
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Prediction of biochemical recurrence after robot‐assisted radical prostatectomy: Analysis of 784 <scp>J</scp>apanese patients
31 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Tokyo Medical University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago